Please refer to BPRD Circular No.03 dated April 09, 2008 on CFS MK-II Financing.

Since CFS MK-II has been discontinued and MTS Financing has been introduced in the capital market, aforementioned circular would be applicable to MTS Financing with immediate effect.

We further advise that because of its peculiar nature, MTS does not envisage counter-party risk assessment and thus needs enhanced risk management measures. In order to mitigate the inherent risks associated with the product, the banks/DFIs as Authorized Financiers (AFs) should take adequate risk management measures and be well aware of the features of product before making MTS financing.

Please acknowledge receipt.